Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Breast Cancer

  Free Subscription


Articles published in Int J Radiat Oncol Biol Phys

Retrieve available abstracts of 78 articles:
HTML format



Single Articles


    October 2021
  1. SAULSBERRY L, Liao C, Huo D
    Hypofractionated Radiotherapy for Breast Cancer: Financial Risk and Expenditures in the U.S. 2008-2017: Expenditure of Hypofractionated Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2021 Oct 9. pii: S0360-3016(21)02901.
    PubMed     Abstract available


  2. CUTTINO LW, McCall L, Kubicky C, Ballman KV, et al
    The Feasibility of Radiotherapy after Breast-Conserving Surgery for Multiple Ipsilateral Breast Cancer: An Initial Report from ACOSOG Z11102 (Alliance) Trial.
    Int J Radiat Oncol Biol Phys. 2021 Oct 8. pii: S0360-3016(21)02872.
    PubMed    


  3. JAGSI R, Griffith KA, Moran JM, Matuszak MM, et al
    Comparative Effectiveness Analysis of 3D-Conformal Radiotherapy versus Intensity Modulated Radiotherapy (IMRT) in a Prospective Multicenter Cohort of Breast Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2021 Oct 8. pii: S0360-3016(21)02871.
    PubMed     Abstract available


  4. VAN VELZEN SGM, Gal R, Teske AJ, van der Leij F, et al
    AI-based radiation dose quantification for estimation of heart disease risk in breast cancer survivors after radiotherapy.
    Int J Radiat Oncol Biol Phys. 2021 Oct 5. pii: S0360-3016(21)02791.
    PubMed     Abstract available


  5. KIM DY, Park E, Heo CY, Jin US, et al
    Influence of Hypofractionated versus Conventional Fractionated Postmastectomy Radiotherapy in Breast Cancer Patients with Reconstruction.
    Int J Radiat Oncol Biol Phys. 2021 Oct 2. pii: S0360-3016(21)02835.
    PubMed     Abstract available


  6. WENG JK, Lei X, Schlembach P, Bloom ES, et al
    Five-Year Longitudinal Analysis of Patient-Reported Outcomes and Cosmesis in a Randomized Trial of Conventionally Fractionated Versus Hypofractionated Whole-Breast Irradiation.
    Int J Radiat Oncol Biol Phys. 2021;111:360-370.
    PubMed     Abstract available


    September 2021
  7. VAN VELZEN SGM, Bruns S, Wolterink JM, Leiner T, et al
    AI-based quantification of planned radiotherapy dose to cardiac structures and coronary arteries in breast cancer patients.
    Int J Radiat Oncol Biol Phys. 2021 Sep 18. pii: S0360-3016(21)02792.
    PubMed     Abstract available


  8. SPEERS C, Murthy VL, Walker EM, Glide-Hurst CK, et al
    Cardiac MRI and blood biomarkers for evaluation of radiation-induced cardiotoxicity in breast cancer patients: results of a phase II clinical trial.
    Int J Radiat Oncol Biol Phys. 2021 Sep 9. pii: S0360-3016(21)02732.
    PubMed     Abstract available


  9. SPEERS CW, Mutter RW
    When Old Becomes New-Repurposing Cytotoxic Chemotherapy With Radiation to Improve Outcomes in Women With Aggressive Forms of Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111:53-55.
    PubMed    


    August 2021
  10. BRADLEY JA, Strauss JB, Bellon JR
    Postmastectomy Bolus: Urban Legend or Sound Practice?
    Int J Radiat Oncol Biol Phys. 2021;110:1370-1372.
    PubMed    


  11. JACOBSON G, Lawrence YR, Appel S, Weiss I, et al
    Benefits of Continuous Positive Airway Pressure (CPAP) During Radiation Therapy: A Prospective Trial.
    Int J Radiat Oncol Biol Phys. 2021;110:1466-1472.
    PubMed     Abstract available


  12. MANUKIAN G, Kivolowitz C, DeAngelis T, Shastri AA, et al
    Caloric Restriction Impairs Regulatory T cells Within the Tumor Microenvironment After Radiation and Primes Effector T cells.
    Int J Radiat Oncol Biol Phys. 2021;110:1341-1349.
    PubMed     Abstract available


  13. PRASANNA PG, Rawojc K, Guha C, Buchsbaum JC, et al
    Normal Tissue Injury Induced by Photon and Proton Therapies: Gaps and Opportunities.
    Int J Radiat Oncol Biol Phys. 2021;110:1325-1340.
    PubMed     Abstract available


  14. NICHOL A, Narinesingh D, Raman S, Germain F, et al
    The Effect of Bolus on Local Control for Patients Treated With Mastectomy and Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2021;110:1360-1369.
    PubMed     Abstract available


    July 2021
  15. LAPEN K, Sabol C, Tin AL, Lynch K, et al
    Development and pilot implementation of a remote monitoring system for acute toxicity using electronic patient-reported outcomes (ePROs) for patients undergoing radiation therapy for breast cancer.
    Int J Radiat Oncol Biol Phys. 2021 Jul 24. pii: S0360-3016(21)02562.
    PubMed     Abstract available


  16. SURA K, Chen PY
    Determining the Optimal Treatment of Locally Advanced Breast Cancer With Sequelae of Dermatomyositis.
    Int J Radiat Oncol Biol Phys. 2021;110:940-941.
    PubMed    


  17. RODIN D, Strauss JB, R Bellon J
    "Standard" Fractionation for Breast Cancer is No Longer Standard.
    Int J Radiat Oncol Biol Phys. 2021;110:925-927.
    PubMed    


  18. NAOUM GE, Taghian AG
    Regional Lymph Nodes Radiation and Breast Cancer Related Lymphedema: Where We Stand.
    Int J Radiat Oncol Biol Phys. 2021;110:1159-1160.
    PubMed    


  19. BOSMA SCJ, van der Leij F, Elkhuizen PHM, Vreeswijk S, et al
    Evaluation of Early Response to Preoperative Accelerated Partial Breast Irradiation (PAPBI) by Histopathology, Magnetic Resonance Imaging, and 18F-fluorodexoyglucose Positron Emission Tomography/Computed Tomography (FDG PET/CT).
    Int J Radiat Oncol Biol Phys. 2021;110:1151-1158.
    PubMed     Abstract available


  20. SMALL W JR, Pugh SL, Wagner LI, Kirshner J, et al
    Psychological Treatment for Patients Receiving Radiation: Results of NRG Oncology/RTOG 0841.
    Int J Radiat Oncol Biol Phys. 2021;110:962-972.
    PubMed     Abstract available


  21. KIM SW, Cho WK, Choi DH, Kim H, et al
    What Is High-Risk Breast Cancer with Pathologically Negative Lymph Nodes for Regional Recurrence?
    Int J Radiat Oncol Biol Phys. 2021 Jul 13. pii: S0360-3016(21)00874.
    PubMed     Abstract available


  22. PURSWANI JM, Oh C, Jaros B, Sandigursky S, et al
    Breast Conservation in Women with Autoimmune Disease: The Role of Active Autoimmune Disease and Hypofractionation on Acute and Late Toxicity in a Case-Controlled Series.
    Int J Radiat Oncol Biol Phys. 2021;110:783-791.
    PubMed     Abstract available


    June 2021
  23. HANNOUN-LEVI JM, Gal J, Van Limbergen E, Chand ME, et al
    Salvage Mastectomy Versus Second Conservative Treatment for Second Ipsilateral Breast Tumor Event: A Propensity Score-Matched Cohort Analysis of the GEC-ESTRO Breast Cancer Working Group Database.
    Int J Radiat Oncol Biol Phys. 2021;110:452-461.
    PubMed     Abstract available


  24. LIU HC, Viswanath DI, Pesaresi F, Xu Y, et al
    Potentiating Antitumor Efficacy Through Radiation and Sustained Intratumoral Delivery of Anti-CD40 and Anti-PDL1.
    Int J Radiat Oncol Biol Phys. 2021;110:492-506.
    PubMed     Abstract available


    May 2021
  25. MUTTER RW, Choi JI, Jimenez RB, Kirova YM, et al
    Proton Therapy for Breast Cancer: A Consensus Statement from the Particle Therapy Cooperative Group (PTCOG) Breast Cancer Subcommittee.
    Int J Radiat Oncol Biol Phys. 2021 May 25. pii: S0360-3016(21)00652.
    PubMed     Abstract available


  26. GERBER NK, Shao H, Chadha M, Deb P, et al
    Radiation without endocrine therapy in older women with stage I estrogen-receptor (ER) positive breast cancer is not associated with a higher risk of second breast cancer events.
    Int J Radiat Oncol Biol Phys. 2021 May 8. pii: S0360-3016(21)00457.
    PubMed     Abstract available


    April 2021
  27. HANNOUN-LEVI JM, Montagne L, Sumodhee S, Schiappa R, et al
    APBI versus ultra APBI in the elderly with low-risk breast cancer: a comparative analysis of oncological outcome and late toxicity.
    Int J Radiat Oncol Biol Phys. 2021 Apr 5. pii: S0360-3016(21)00314.
    PubMed     Abstract available


  28. BOUTRUS RR, El Sherif S, Abdelazim Y, Bayomy M, et al
    Once Daily Versus Twice Daily External Beam Accelerated Partial Breast Irradiation: A Randomized Prospective Study.
    Int J Radiat Oncol Biol Phys. 2021;109:1296-1300.
    PubMed     Abstract available


  29. MENDEZ ROMERO A, Schillemans W, van Os R, Koppe F, et al
    The Dutch-Belgian Registry of Stereotactic Body Radiation Therapy for Liver Metastases: Clinical Outcomes of 515 Patients and 668 Metastases.
    Int J Radiat Oncol Biol Phys. 2021;109:1377-1386.
    PubMed     Abstract available


  30. KUMAR KA, Balazy KE, Gutkin PM, Jacobson CE, et al
    Association Between Patient Education Videos and Knowledge of Radiation Treatment.
    Int J Radiat Oncol Biol Phys. 2021;109:1165-1175.
    PubMed     Abstract available


  31. JARVIS LA, Hachadorian RL, Jermyn M, Bruza P, et al
    Initial Clinical Experience of Cherenkov Imaging in External Beam Radiation Therapy Identifies Opportunities to Improve Treatment Delivery.
    Int J Radiat Oncol Biol Phys. 2021;109:1627-1637.
    PubMed     Abstract available


    March 2021
  32. POLGAR C, Major T, Takacsi-Nagy Z, Fodor J, et al
    Breast-Conserving Surgery Followed by Partial or Whole Breast Irradiation: Twenty-Year Results of a Phase 3 Clinical Study.
    Int J Radiat Oncol Biol Phys. 2021;109:998-1006.
    PubMed     Abstract available


  33. BELLON JR, Chen YH, Rees R, Taghian AG, et al
    A phase I dose-escalation trial of radiation therapy and concurrent cisplatin for stage II and III triple-negative breast cancer.
    Int J Radiat Oncol Biol Phys. 2021 Mar 10. pii: S0360-3016(21)00242.
    PubMed     Abstract available


  34. VAN DEN BOGAARD VAB, Spoor DS, van der Schaaf A, van Dijk LV, et al
    The Importance of Radiation Dose to the Atherosclerotic Plaque in the Left Anterior Descending Coronary Artery for Radiation-Induced Cardiac Toxicity of Breast Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2021 Mar 10. pii: S0360-3016(21)00244.
    PubMed     Abstract available


  35. SHAHI J, Poon I, Ung YC, Tsao M, et al
    Stereotactic Body Radiation Therapy for Mediastinal and Hilar Lymph Node Metastases.
    Int J Radiat Oncol Biol Phys. 2021;109:764-774.
    PubMed     Abstract available


  36. DE PAULA U, D'Angelillo RM, Andrulli AD, Apicella G, et al
    Long-Term Outcomes of Once-Daily Accelerated Partial-Breast Irradiation With Tomotherapy: Results of a Phase 2 Trial.
    Int J Radiat Oncol Biol Phys. 2021;109:678-687.
    PubMed     Abstract available


    February 2021
  37. CHANG WI, Han MG, Kang MH, Park JM, et al
    PI3Kalphadelta Inhibitor Combined With Radiation Enhances the Antitumor Immune Effect of Anti-PD1 in a Syngeneic Murine Triple-Negative Breast Cancer Model.
    Int J Radiat Oncol Biol Phys. 2021 Feb 25. pii: S0360-3016(21)00085.
    PubMed     Abstract available


  38. POLGAR C, Strnad V, Hannoun-Levi JM, Major T, et al
    Reply to the Editor - Do we think seriously that a single shot of 5 Gy intraoperative irradiation at 1 cm is able to avoid any local recurrence or non-breast cancer death after breast-conserving surgery?
    Int J Radiat Oncol Biol Phys. 2021 Feb 24. pii: S0360-3016(21)00198.
    PubMed    


  39. VAIDYA JS, Bulsara M, Sperk E, Massarut S, et al
    TARGIT-IORT during lumpectomy for breast cancer - better for patients than other PBI approaches.
    Int J Radiat Oncol Biol Phys. 2021 Feb 24. pii: S0360-3016(21)00199.
    PubMed    


  40. WANG B, Huang X, Liang H, Yang H, et al
    PLK1 inhibition sensitizes breast cancer cells to radiation via suppressing autophagy.
    Int J Radiat Oncol Biol Phys. 2021 Feb 20. pii: S0360-3016(21)00203.
    PubMed     Abstract available


  41. MCDUFF SGR, Bellon JR, Shannon KM, Gadd MA, et al
    ATM Variants in Breast Cancer: Implications for Breast Radiotherapy Treatment Recommendations.
    Int J Radiat Oncol Biol Phys. 2021 Feb 2. pii: S0360-3016(21)00119.
    PubMed     Abstract available


  42. PINKAWA M
    Spinal Cord Reirradiation:Balancing Benefit Against Risks.
    Int J Radiat Oncol Biol Phys. 2021;109:312-313.
    PubMed    


  43. PASALIC D, Strom EA, Allen PK, Williamson TD, et al
    Proton Accelerated Partial Breast Irradiation: Clinical Outcomes at a Planned Interim Analysis of a Prospective Phase 2 Trial.
    Int J Radiat Oncol Biol Phys. 2021;109:441-448.
    PubMed     Abstract available


    January 2021
  44. RAHIMI A, Morgan HE, Kim DW, Zhang Y, et al
    Cosmetic outcomes of a phase I dose escalation study of 5-fraction stereotactic partial breast irradiation for early stage breast cancer.
    Int J Radiat Oncol Biol Phys. 2021 Jan 18. pii: S0360-3016(21)00067.
    PubMed     Abstract available


  45. CHUNG SY, Oh J, Chang JS, Shin J, et al
    Risk of Cardiac Disease in Breast Cancer Patients: Impact of Patient-Specific Factors and Individual Heart Dose from Three-Dimensional Radiotherapy Planning.
    Int J Radiat Oncol Biol Phys. 2021 Jan 6. pii: S0360-3016(21)00003.
    PubMed     Abstract available


  46. CHOI SH, Chang JS, Son NH, Hong CS, et al
    Risk of Hypothyroidism in Women after Radiotherapy for Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021 Jan 4. pii: S0360-3016(20)34743.
    PubMed     Abstract available



  47. Erratum to: Sperduto PW, Mesko S, Li J, et al. Beyond an Updated Graded Prognostic Assessment (Breast GPA): A Prognostic Index and Trends in Treatment and Survival in Breast Cancer Brain Metastases From 1985 to Today. Int J Radiat Oncol Biol Phys 2020
    Int J Radiat Oncol Biol Phys. 2021;109:303.
    PubMed    


  48. POPPE MM, Khan AJ
    In Reply to Dyer et al.
    Int J Radiat Oncol Biol Phys. 2021;109:301-302.
    PubMed    


  49. DYER BA, Flanagan MR, Said HK, Kim J, et al
    In Regard to Poppe et al.
    Int J Radiat Oncol Biol Phys. 2021;109:300-301.
    PubMed    


  50. TOM MC, Sittenfeld SMC, Shah C, Bauer-Nilsen K, et al
    Use of a Radiation Tumor Bed Boost After Breast-Conserving Surgery and Whole-Breast Irradiation: Time Trends and Correlates.
    Int J Radiat Oncol Biol Phys. 2021;109:273-280.
    PubMed     Abstract available


    December 2020
  51. CLASEN SC, Shou H, Freedman G, Plastaras JP, et al
    Early cardiac effects of contemporary radiation therapy in breast cancer patients.
    Int J Radiat Oncol Biol Phys. 2020 Dec 16. pii: S0360-3016(20)34654.
    PubMed     Abstract available


  52. VASMEL JE, Vreuls CP, Manson QF, Charaghvandi RK, et al
    Tumor infiltrating lymphocytes in low-risk breast cancer patients treated with single dose pre-operative partial breast irradiation.
    Int J Radiat Oncol Biol Phys. 2020 Dec 14. pii: S0360-3016(20)34655.
    PubMed     Abstract available


  53. HORNER-RIEBER J, Forster T, Hommertgen A, Haefner MF, et al
    Intensity-modulated radiotherapy (IMRT) with simultaneously integrated boost shortens treatment time and is non-inferior to conventional radiotherapy followed by sequential boost in adjuvant breast cancer treatment: results of a large randomized phase
    Int J Radiat Oncol Biol Phys. 2020 Dec 12. pii: S0360-3016(20)34651.
    PubMed     Abstract available


  54. FRANCIS DM, Brower JV
    Post-Mastectomy Radiation After Immediate Reconstruction for Multifocal Early-Stage Breast Cancer; to Irradiate or Not?
    Int J Radiat Oncol Biol Phys. 2020;108:1129-1130.
    PubMed    


  55. ZEIDAN YH, Poortmans P
    Don't Miss the Devil in the Details.
    Int J Radiat Oncol Biol Phys. 2020;108:1133.
    PubMed    


  56. MCCALL AR, Son CH
    Young and High Risk.
    Int J Radiat Oncol Biol Phys. 2020;108:1132-1133.
    PubMed    


  57. ROYCE TJ, Marks LB
    Balancing the Benefits and Harms of Postmastectomy Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2020;108:1131.
    PubMed    


  58. NAOUM GE, Taghian AG
    Complications May Outweigh the Benefits.
    Int J Radiat Oncol Biol Phys. 2020;108:1131-1132.
    PubMed    


  59. MUTTER RW, Hepel JT
    Accelerated Partial Breast Radiation: Information on Dose, Volume, Fractionation, and Efficacy from Randomized Trials.
    Int J Radiat Oncol Biol Phys. 2020;108:1123-1128.
    PubMed    


  60. HEPEL JT, Leonard KL, Sha S, Graves TA, et al
    Phase 2 Trial of Accelerated Partial Breast Irradiation (APBI) Using Noninvasive Image Guided Breast Brachytherapy (NIBB).
    Int J Radiat Oncol Biol Phys. 2020;108:1143-1149.
    PubMed     Abstract available


  61. DETAPPE A, Mathieu C, Jin C, Agius MP, et al
    Anti-MUC1-C Antibody-Conjugated Nanoparticles Potentiate the Efficacy of Fractionated Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2020;108:1380-1389.
    PubMed     Abstract available


    November 2020
  62. BERNSTEIN-MOLHO R, Laitman Y, Galper S, Jacobson G, et al
    Locoregional treatments and ipsilateral breast cancer recurrence rates in BRCA1/2 mutation carriers.
    Int J Radiat Oncol Biol Phys. 2020 Nov 28. pii: S0360-3016(20)34598.
    PubMed     Abstract available


  63. SHI J, Xu K, Keyvanloo A, Udayakumar TS, et al
    A Multimodality Image Guided Precision Radiation Research Platform: Integrating X-ray, Bioluminescence, and Fluorescence Tomography With Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2020;108:1063-1072.
    PubMed     Abstract available


  64. SHUMWAY DA, Motomura A, Griffith KA, Hayman JA, et al
    Patient Perceptions in a Nonblinded Randomized Trial of Radiation Therapy Technologies: A Novel Survey Study Exploring Therapeutic Misconception.
    Int J Radiat Oncol Biol Phys. 2020;108:867-875.
    PubMed     Abstract available


    October 2020
  65. BOYAGES J, Vicini FA, Shah C, Koelmeyer LA, et al
    The risk of subclinical breast cancer-related lymphedema by the extent of axillary surgery and regional node irradiation-a randomized controlled trial.
    Int J Radiat Oncol Biol Phys. 2020 Oct 27. pii: S0360-3016(20)34440.
    PubMed     Abstract available


  66. KRISHNAN S, Narayan HK, Freedman G, Plastaras JP, et al
    Early Changes in Physical Activity and Quality of Life with Thoracic Radiation Therapy in Breast Cancer, Lung Cancer, and Lymphoma.
    Int J Radiat Oncol Biol Phys. 2020 Oct 24. pii: S0360-3016(20)34406.
    PubMed     Abstract available


  67. BILLENA C, Wilgucki M, Flynn J, Modlin L, et al
    10-Year Breast Cancer Outcomes in Women
    Int J Radiat Oncol Biol Phys. 2020 Oct 24. pii: S0360-3016(20)34437.
    PubMed     Abstract available


  68. LING DC, Vargo JA, Beriwal S
    Breast, Prostate, and Rectal Cancer: Should 5-5-5 Be a New Standard of Care?
    Int J Radiat Oncol Biol Phys. 2020;108:390-393.
    PubMed    


    September 2020
  69. LOAP P, Loirat D, Berger F, Ricci F, et al
    Combination of Olaparib and radiotherapy for triple negative breast cancer: preliminary results of the RADIOPARP phase I trial.
    Int J Radiat Oncol Biol Phys. 2020 Sep 21. pii: S0360-3016(20)34304.
    PubMed     Abstract available


    August 2020
  70. LAUCIS AM, Jagsi R, Griffith KA, Dominello MM, et al
    The Role of Facility Variation on Racial Disparities in Use of Hypofractionated Whole Breast Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2020;107:949-958.
    PubMed     Abstract available


    July 2020
  71. POPPE MM, Yehia ZA, Baker C, Goyal S, et al
    5-Year Update of a Multi-Institution, Prospective Phase 2 Hypofractionated Postmastectomy Radiation Therapy Trial.
    Int J Radiat Oncol Biol Phys. 2020;107:694-700.
    PubMed     Abstract available


  72. LALANI N, Jimenez RB, Yeap B
    Understanding Propensity Score Analyses.
    Int J Radiat Oncol Biol Phys. 2020;107:404-407.
    PubMed    


    June 2020
  73. STRAUSS JB
    Extensive Lymphovascular Invasion Warrants Extensive Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2020;107:234-235.
    PubMed    


  74. SHAH C, Vicini F
    Early Stage, But Not So Routine.
    Int J Radiat Oncol Biol Phys. 2020;107:233.
    PubMed    


  75. HARA JH, Son CH
    From Chemo Rejection to Regional Radiation: A Post-Mastectomy Dilemma.
    Int J Radiat Oncol Biol Phys. 2020;107:232.
    PubMed    


  76. OLADERU OT, Ho AY
    The Local Control of Systemic Therapy.
    Int J Radiat Oncol Biol Phys. 2020;107:233-234.
    PubMed    


    May 2020
  77. NAOUM GE, Taghian AG
    In Reply to Kim et al.
    Int J Radiat Oncol Biol Phys. 2020;107:224.
    PubMed    


  78. KIM J, Chang JS, Lee DW, Song SY, et al
    In Regard to Naoum et al.
    Int J Radiat Oncol Biol Phys. 2020;107:223.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: